Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Biocatalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN105734028A reveals mutant epoxide hydrolase for high-purity R-epichlorohydrin. Enhances stability and activity for reliable pharmaceutical intermediate supply chains.
Patent CN105602922A reveals efficient amidase catalysis for gabapentin intermediates. Achieve high purity and cost reduction in pharmaceutical intermediates manufacturing with scalable biocatalytic routes.
Patent CN111172213B reveals dual-enzyme tandem method for L-ABA. Offers cost reduction and supply chain reliability for pharma intermediates.
Patent CN106282135A details a robust RrQR enzyme process for (R)-3-quinuclidinol, offering superior stability and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN114317472B details a novel biocatalytic route for (S)-nornicotine using immobilized imine reductase, offering superior purity and scalable manufacturing for pharmaceutical intermediates.
Patent CN114045271B reveals high-efficiency biocatalysis for Atazanavir intermediates. Discover cost reduction and supply chain reliability with immobilized enzyme technology.
Patent CN113652408A reveals a novel carbonyl reductase mutant for efficient (R)-4-chloro-3-hydroxybutyric acid ethyl ester production, offering superior yield and green manufacturing advantages.
Patent CN112481320B details a novel recombinant lactamase for producing optically pure (-)-γ-lactam. This breakthrough offers superior stability and stereoselectivity for antiviral drug synthesis.
Patent CN111057735B details a novel esterase route for high-purity chiral intermediates. Discover cost-effective manufacturing and reliable supply chain solutions.
Patent CN104178469B reveals high-purity enzymatic route for Cilastatin intermediate. Offers significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN105505904A reveals enhanced nitrilase mutant for high-purity (R)-mandelic acid production with improved selectivity and activity for reliable supply.
Patent CN103013945B details a novel epoxide hydrolase mutant enhancing hydrolytic activity and enantioselectivity for beta-blocker synthesis, offering significant cost and supply chain advantages.
Patent CN113801903B reveals enzymatic route for sitagliptin intermediate offering high purity and supply chain stability for global API manufacturers.
Novel one-step enzymatic route for L-carnosine reduces cost and complexity. Reliable supply chain partner for high-purity pharmaceutical intermediates and scalable production.
Patent CN117535268A reveals high-purity esterase resolution. Achieve cost reduction in pharmaceutical intermediates manufacturing with scalable biocatalysis.
Patent CN106282134A details KgQR enzyme for high yield synthesis. Offers significant cost reduction and supply chain reliability for global pharmaceutical intermediate manufacturing partners.
Patent CN110438194B details a novel lipase F11 for resolving DL-tropine methyl ester with >99% ee. Ideal for reliable pharmaceutical intermediate supply chains.
Patent CN102876734B details a novel carbonyl reductase for high-purity chiral alcohol production, offering significant cost and supply chain advantages for API intermediates.
Patent CN111500652A reveals a novel enzymatic dynamic kinetic resolution for florfenicol. Discover cost-effective, high-purity veterinary drug intermediate manufacturing solutions.
Patent CN109609536B reveals efficient whole-cell synthesis. Reduces cost and improves supply chain reliability for high-purity L-carnosine manufacturing.